Weight loss drugs may have unexpected effect on impulsive violence, study finds

A new study from Rutgers University has uncovered something researchers weren't looking for. People taking GLP-1 drugs like Ozempic and Wegovy, medications typically prescribed for weight loss and diabetes management, appear to show less violent behavior, even when they have impulsive tendencies.

The finding is surprising because these medications were designed to regulate blood sugar and appetite, not to influence how people respond to anger or frustration. But according to the research, there seems to be a disconnect happening between having an impulse and acting on it violently among those taking the drugs.

What the research found

The Rutgers team looked at people who naturally score high on measures of impulsivity. Normally, higher impulsivity is associated with a greater likelihood of violent behavior. It's a pattern that has been documented across many studies over the years.

But in people taking GLP-1 medications, that connection appeared weaker. The usual link between impulsive traits and violent actions seemed to fade, suggesting that something about these drugs might be changing how the brain processes the urge to act aggressively.

The researchers are careful to point out that they have not proven cause and effect. This type of study shows an association, a pattern, but cannot definitively say the medication is responsible for the change. There could be other factors at play, from improved physical health to better mood as weight drops.

*Photo: Artem Podrez · Pexels*

Why this matters beyond weight loss

GLP-1 drugs have already made headlines for their effectiveness in helping people lose weight. In recent years, they have become some of the most talked about medications in healthcare, with demand sometimes outstripping supply.

But researchers have been noticing other effects too. Some people report changes in their relationship with alcohol, reduced cravings for cigarettes, and shifts in addictive behaviors. The idea that these drugs might influence impulse control more broadly is starting to gain attention in scientific circles.

The brain has GLP-1 receptors in areas that regulate reward, motivation and decision making. When these medications activate those receptors, they may be doing more than just telling the body it's full. They might be influencing the circuits that govern how we respond to urges of all kinds, including the impulse to lash out.

This is early territory. The Rutgers study does not suggest that GLP-1 drugs should be prescribed to reduce aggression, and the researchers themselves emphasize caution. But the finding opens a door to questions about how metabolic health and behavior are connected in ways we're only beginning to understand.

*Photo: Nataliya Vaitkevich · Pexels*

What comes next

The study will likely prompt more research into the psychological and behavioral effects of these medications. Scientists will want to know whether the pattern holds up in larger groups, in different populations, and over longer periods of time.

They will also want to understand the mechanism. Is it a direct effect on brain chemistry, or is it indirect, perhaps through improved sleep, reduced inflammation, or better overall health? All of these factors can influence mood and self-control.

For now, the takeaway is modest but intriguing. A class of drugs designed to help the body manage sugar and weight may also be touching something deeper in how we regulate impulse and action. It's a reminder that the brain and body are not separate systems, and that changing one can ripple through the other in unexpected ways.

Anyone currently taking or considering GLP-1 medications should continue to follow their doctor's guidance. These drugs are not without side effects, and they are not appropriate for everyone. But this research adds another layer to our understanding of how they work and what they might be capable of beyond their original purpose.

The study was published by researchers at Rutgers and is available through ScienceDaily.

For podcasters exploring the crossroads of physical and mental health, this is a story worth watching. It speaks to the complexity of human behavior and the surprising ways that biology, chemistry and choice intersect. As we learn more about these medications, we may also learn more about the hidden connections that shape how we feel, think and act in the world.